AG
HRMY icon

Algert Global’s Harmony Biosciences HRMY Stock Holding History

Algert Global’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Buy
144,849
+33,591
+30% +$1.06M 0.06% 509
2026
Q1 		$3.12M Sell
111,258
-248,560
-69% -$8.15M 0.05% 588
2025
Q4 		$13.5M Buy
359,818
+91,210
+34% +$3M 0.21% 124
2025
Q3 		$7.4M Sell
268,608
-880
-0.3% -$30.3K 0.12% 281
2025
Q2 		$8.52M Buy
269,488
+55,650
+26% +$1.79M 0.18% 168
2025
Q1 		$7.1M Sell
213,838
-17,070
-7% -$612K 0.18% 167
2024
Q4 		$7.95M Buy
230,908
+139,967
+154% +$4.81M 0.19% 159
2024
Q3 		$3.64M Sell
90,941
-11,670
-11% -$410K 0.1% 358
2024
Q2 		$3.1M Sell
102,611
-25,000
-20% -$752K 0.1% 325
2024
Q1 		$4.29M Sell
127,611
-32,530
-20% -$1.04M 0.17% 200
2023
Q4 		$5.17M Buy
160,141
+124,456
+349% +$3.47M 0.21% 131
2023
Q3 		$1.17M Sell
35,685
-4,730
-12% -$164K 0.06% 532
2023
Q2 		$1.42M Buy
40,415
+26,750
+196% +$923K 0.06% 520
2023
Q1 		$446K Sell
13,665
-3,728
-21% -$170K 0.02% 856
2022
Q4 		$958K Buy
17,393
+2,390
+16% +$131K 0.05% 587
2022
Q3 		$664K Sell
15,003
-282
-2% -$13.8K 0.04% 717
2022
Q2 		$745K Sell
15,285
-9,996
-40% -$450K 0.06% 600
2022
Q1 		$1.23M Buy
+25,281
New +$1.03M 0.08% 431

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's HRMY Position: Q2 2026 in Review

Algert Global increased its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, buying an estimated $1.06M and bringing the position to 144,849 shares worth $5.27M. The position accounts for 0.06% of the portfolio, ranked #509.

Algert Global first reported a position in HRMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $13.5M in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Algert Global held 144,849 shares of Harmony Biosciences worth $5.27M as of Q2 2026.
  • Algert Global bought 33,591 Harmony Biosciences shares in Q2 2026, an estimated $1.06M.
  • Harmony Biosciences made up 0.06% of Algert Global's portfolio in Q2 2026, its #509 holding.
  • Algert Global first reported a position in Harmony Biosciences in Q1 2022 and has held it in 18 quarters since.
  • Algert Global's Harmony Biosciences position peaked at $13.5M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.